Stockreport

ReShape Lifesciences misses by $0.30, misses on revenue [Seeking Alpha]

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com
PDF ReShape Lifesciences misses by $0.30, misses on revenueReShape Lifesciences (NASDAQ:RSLS): Q4 EPS of -$0.45misses by $0.30.Revenue of $0.79M (+464.3% Y/Y)misses by $0.01 [Read more]